Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Achillion Pharmaceuticals, Inc. (NQ: ACHN)
7.750 USD  +0.200 (+2.65%)
Official Closing Price  /  Updated: 4:30 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Achillion Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Budget Talks Collapse In Netherlands, Markets Slump
April 23, 2012
A breakdown in budget negotiations in the Netherlands renewed concerns about the European economy sending the markets tumbling to a sharply lower open with the Dow slumping 161 points to 12,867. Nasdaq... Read More
category Market News
from MarketMinute.com Market Updates
Achillion (ACHN) Updates on EQT Data from Segment 2 of ACH-1625 Phase 2a
April 23, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7363048 for the full story. Read More
from StreetInsider.com News Articles
Achillion Clarifies End of Treatment Data From Phase 2a Trial With ACH-1625 Based Regimen in Hepatitis C
April 23, 2012
from GlobeNewswire News Releases
Pre-Open Movers 4/23: (RDEA) (CEDC) (KERX) Higher; (ACHN) (K) (WMT) Lower (more...)
April 23, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7363026 for the full story. Read More
from StreetInsider.com News Articles
JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform
April 23, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7362548 for the full story. Read More
from StreetInsider.com News Articles
Achillion (ACHN) Presents Strong Data from ACH-1625 Phase 2a; Safety Profile Similar
April 23, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7362277 for the full story. Read More
from StreetInsider.com News Articles
Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C
April 21, 2012
Posters Detailing ACH-1625, ACH-3102 and ACH-2928 Presented at the International Liver Congress(TM) 2012 Read More
from GlobeNewswire News Releases
Baird Reiterates an 'Outperform' on Achillion Pharmaceuticals (ACHN); Buy on Weakness
April 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7358883 for the full story. Read More
from StreetInsider.com News Articles
Brean Murray Carret & Co. Out In Defense of Achillion Pharmaceuticals (ACHN); Superficial Read-Through
April 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7358412 for the full story. Read More
from StreetInsider.com News Articles
Unusual 11 Mid-Day Movers 04/19: (HGSI) (MLNX) (QIHU) Higher; (HUSA) (ACHN) (GNTX) Lower
April 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7358046 for the full story. Read More
from StreetInsider.com News Articles
Hepatitis C drug stocks back in play
April 19, 2012
Hepatitis C specialists Gilead, Idenix and Achillion were back in play Thursday, as investors reacted to positive data on Gilead’s experimental drug GS-7977. Read More
category IDIX , Biotechnology , Retail , and 12 more.
from MarketWatch
Morning Movers 04/19: (HGSI) (MLNX) (QIHU) (SYNT) Higher; (HUSA) (ACHN) (GNTX) Lower
April 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7357638 for the full story. Read More
from StreetInsider.com News Articles
Mixed Open As Existing Home Sales Fall
April 19, 2012
The markets opened mixed with the Dow losing 24 points to 13,008 while Nasdaq gained 10 points to 3041 as sales of existing homes fell in March. Read More
category Market News
from MarketMinute.com Market Updates
Achillion (ACHN) Shares Slammed, Gilead (GILD), Idenix (IDIX) Rip on New HCV Treatment Data
April 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7357166 for the full story. Read More
from StreetInsider.com News Articles
UBS Upgrades Achillion Pharmaceuticals (ACHN) to Neutral
April 19, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7357132 for the full story. Read More
from StreetInsider.com News Articles
Credit Suisse Starts Achillion Pharmaceuticals (ACHN) at Outperform
April 17, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7348813 for the full story. Read More
from StreetInsider.com News Articles
UPDATE - UBS Initiates Coverage on Achillion Pharma (ACHN) with a Neutral; All-Oral Combo Already Priced In
April 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7340700 for the full story. Read More
from StreetInsider.com News Articles
New Ratings from Analysts
April 12, 2012
New York, April 12th (TradersHuddle.com) - Pre-market new initiations and ratings. T Rowe Price ( NASDAQ:TROW ) was initiated with a Market Perform and a target price of $66 at BMO Capital. . Read More... Read More
from TradersHuddle.com
UBS Starts BMRN, RDEA, ARIA at Buy, ITMN, ACHN, HGSI, IRWD at Neutral
April 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7339963 for the full story. Read More
from StreetInsider.com News Articles
Brean Murray Carret & Co. Maintains a 'Buy' on Achillion Pharmaceuticals (ACHN); Becoming Top Hec C Play
April 05, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7327449 for the full story. Read More
from StreetInsider.com News Articles
Brean Murray Adds Achillion (ACHN), Pitney Bowes (PBI), Vivus (VVUS) to 'Focus List'; Removes Gilead (GILD)
April 02, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7313292 for the full story. Read More
from StreetInsider.com News Articles
Wedbush Assumes Coverage on Achillion Pharmaceuticals (ACHN) at Outperform; Optimism from Pipeline
March 27, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7299604 for the full story. Read More
from StreetInsider.com News Articles
Achillion Pharmaceuticals, Inc. (ACHN) Misses Q4 EPS by 2c; Guides FY12
March 08, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7251833 for the full story. Read More
from StreetInsider.com News Articles
Achillion Reports 2011 Fourth Quarter and Year-End Financial Results
March 08, 2012
Conference Call and Webcast to be Held Today, March 8th, at 8:30am ET Read More
from GlobeNewswire News Releases
Achillion Fourth Quarter and Full Year 2011 Financial Release and Conference Call Alert
March 02, 2012
Conference Call and Live Webcast Will be Hosted at 8:30 a.m. on March 8, 2012 Read More
from GlobeNewswire News Releases
Achillion to Present at Two Upcoming Investor Conferences
March 01, 2012
from GlobeNewswire News Releases
AMRS, KWK, ACHN, DNDN, and JAZZ Could See Big Gains, Reports Thestockfather.com
February 25, 2012
from EmailWire.Com Press Releases
2012 Economic Outlook - Report Highlights Achillion Pharmaceuticals, Inc. and Fusion-IO, Inc.
February 22, 2012
from Marketwired News Releases
Indices Close Mixed on Late Rally
February 17, 2012
Indices Close Mixed on Late Rally by Harry Boxer, TheTechTrader.com The stock market indices closed mixed on the day, and were kind of choppy, with a move sharply lower in the morning. They stabilized... Read More
from Harry's Hotline by Harry Boxer
Indices Close Mixed on Late Rally
February 17, 2012
Indices Close Mixed on Late Rally by Harry Boxer, TheTechTrader.com The stock market indices closed mixed on the day, and were kind of choppy, with a move sharply lower in the morning. They stabilized... Read More
from Harry's Hotline by Harry Boxer
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here